• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS MEDICAL SYSTEMS AVALON FM20 FETAL MONITOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS MEDICAL SYSTEMS AVALON FM20 FETAL MONITOR Back to Search Results
Model Number M2702A
Medical Device Problem Code Device Operates Differently Than Expected (2913)
Health Effect - Clinical Code Death (1802)
Date of Event 08/13/2017
Type of Reportable Event Death
Additional Manufacturer Narrative
A follow up report will be submitted once the investigation is complete.
 
Event or Problem Description
The customer is questioning if the maternal heart rate (mhr) can be recorded as the fetal heart rate (fhr).There was a neonatal patient death reported 3 days after the delivery.The device was used for monitoring at the time of the alleged malfunction.
 
Additional Manufacturer Narrative
During the birth on (b)(6), a drop of the fhr was seen at 14:40.The baby was born at 14:59 with an apgar score of 2, measured at 1 minute and 5 minutes after birth.The apgar score is a method to quickly summarize the health of newborn children.The baby passed away 3 days after birth due to hypoxic ischemic encephalopathy (hie).The customer provided the trace for the adverse event.The software version of the device is f.01.55.The trace it self was printed from a surveillance system, thus no information about the transducer and used monitor was available on the trace.The patient was monitored with a toco transducer and an ultrasound transducer.The maternal heart rate was not monitored, thus no coincidence notation between a maternal heart rate and a fetal heart rate was possible for instances when the ultrasound transducer detected the maternal pulse (e.G.From the aorta abdominalis) instead the fetal heart rate.The trace has been evaluated by a philips physician and an external midwife.They stated that the trace starts with showing signs of compromised fetal well-being through low variability.At 13:36 the fetal trace shows additional decelerations as another sign for clinical deterioration.At 14:06 the fetal trace changes again.The trace shows less decelerations and normal variability.The fhr did not react to contractions any more.This would be an unlikely, sudden clinical improvement of the fetus and is probably caused by the ultrasound switching to the prominent pulse source of the mother.The fetal heart movements are probably too weak or gone from that moment onwards.The device was tested by an engineer, no malfunction could be identified.The problem was solved by instructing the customer which is considered as all that is warranted for this issue.The product remains at the customer site and is used in the labor and delivery ward.Additionally, the available information from this report does not support that this failure represents a systemic, design, or labeling problem.No further investigation or action is warranted.
 
Additional Manufacturer Narrative
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AVALON FM20 FETAL MONITOR
Common Device Name
FETAL MONITOR
Manufacturer (Section D)
PHILIPS MEDICAL SYSTEMS
hewlett-packard str.2
boeblingen 71034
GM  71034
MDR Report Key6951421
Report Number9610816-2017-00333
Device Sequence Number12138158
Product Code HGM
Combination Product (Y/N)N
PMA/510(K) Number
K052795
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,user facility
Type of Report Initial,Followup,Followup
Report Date (Section B) 10/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberM2702A
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 10/11/2017
Supplement Date Received by Manufacturer10/11/2017
10/11/2017
Initial Report FDA Received Date10/16/2017
Supplement Report FDA Received Date12/07/2017
02/27/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age3 DA
-
-